NCT06918028

Brief Summary

To establish a multimodal fundus image report generation model to realize an interpretable system for multiple fundus diseases, multimodal image analysis, diagnosis, and treatment decision automatic reporting based on weakly labeled training data. Construct an interpretable feature fusion network for the clinical and imaging features of fundus lesions, and we hope to extract new imaging markers that can predict the occurrence and progression of various fundus lesions at an early stage, and ultimately verify them in real clinical data, further providing possible directions for exploring the molecular mechanisms of refractory fundus lesions, and may also provide new ideas for the precise prevention and treatment of fundus lesions.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9,999

participants targeted

Target at P75+ for all trials

Timeline
7mo left

Started May 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress64%
May 2025Dec 2026

First Submitted

Initial submission to the registry

March 3, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 9, 2025

Completed
22 days until next milestone

Study Start

First participant enrolled

May 1, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

April 9, 2025

Status Verified

October 1, 2024

Enrollment Period

7 months

First QC Date

March 3, 2025

Last Update Submit

April 5, 2025

Conditions

Outcome Measures

Primary Outcomes (5)

  • Fundus Fluorescein Angiography (FFA) images with corresponding report

    Fundus Fluorescein Angiography(FFA) images with corresponding report were collected. FFA allows dynamic observation of changes in retinal blood vessels and lesions.

    Baseline

  • Indocyanine Green Angiography (ICGA) images with report

    Indocyanine Green Angiography (ICGA) images with corresponding report were collected. ICGA allows dynamic observation of changes in choroidal blood vessels and lesions.

    Baseline

  • Fundus photography with corresponding report

    Fundus photography images with corresponding report were collected. Fundus photography provides observation of morphological manifestations of the retina, the retinal blood vessels, the optic nerve, as well as lesions on the retina.

    Baseline

  • Optical coherence tomography (OCT) images with corresponding report

    Optical coherence tomography (OCT) images with corresponding report were collected. OCT images provides observation of changes in retinal thickness, morphology and manifestations of lesions in each retinal or choroidal layer, as well as lesions in the macular area and optic nerve

    Baseline

  • Optical coherence tomography angiography (OCTA) images with corresponding report

    Optical coherence tomography angiography (OCTA) images with corresponding report were collected. OCTA images provides observation of the density, morphology, and manifestations of retinal blood vessels, as well as the morphology and manifestations of retinal lesions

    Baseline

Secondary Outcomes (5)

  • Bilingual Evaluation Understudy (BLEU) analysis

    Through study completion, an average of 1 year

  • Metric for Evaluation of Translation with Explicit Ordering (METEOR) analysis

    Through study completion, an average of 1 year

  • Recall-Oriented Understudy for Gisting Evaluation (ROUGE) analysis

    Through study completion, an average of 1 year

  • Pearson correlation analysis

    Through study completion, an average of 1 year

  • Intersection-Over-Union (IOU) analysis

    Through study completion, an average of 1 year

Study Arms (2)

Disease group

With retinal or choroidal diseases

Other: With fundus diseases

Normal group

Without retinal or choroidal diseases

Other: Without fundus diseases

Interventions

With fundus diseases

Disease group

Without fundus diseases

Normal group

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The clinically collected fundus examination images and corresponding reports, including various categories of fundus lesions or normal findings, obtained from examinations conducted at the Zhongshan Ophthalmic Center.

You may qualify if:

  • Disease group: All multimodal fundus examination images containing fundus lesions, examined from January 2011 to December 2023, including fundus photography, as well as OCT, OCTA, FFA, ICGA, B-ultrasound and corresponding imaging reports. Images could be either clear or unclear, reports are either complete or incomplete.
  • Normal group: All multimodal fundus examination images without fundus lesions, examined from January 2011 to December 2023, including fundus photography, as well as OCT, OCTA, FFA, ICGA, B-ultrasound and corresponding imaging reports. Images could be either clear or unclear, reports are either complete or incomplete.

You may not qualify if:

  • Disease group: 1. The image has serious quality problems; 2. The diagnostic report lacks key information.
  • Normal group: 1. The image has serious quality problems; 2. The diagnostic report lacks key information.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongshan Ophthalmic Center

Guangzhou, Guangdong, 510080, China

Location

MeSH Terms

Conditions

Retinal DiseasesChoroid DiseasesMyopia, DegenerativeDiabetic RetinopathyMacular DegenerationChoroidal Neovascularization

Condition Hierarchy (Ancestors)

Eye DiseasesUveal DiseasesMyopiaRefractive ErrorsDiabetic AngiopathiesVascular DiseasesCardiovascular DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System DiseasesRetinal DegenerationNeovascularization, PathologicMetaplasiaPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Wenjia Cai, Ph.D.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 3, 2025

First Posted

April 9, 2025

Study Start

May 1, 2025

Primary Completion

December 1, 2025

Study Completion (Estimated)

December 1, 2026

Last Updated

April 9, 2025

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations